SCHEMBL19651854

SCHEMBL19651854

CC(C)c1cc(C(=O)N2CCOCC2)c2ncn(C)c2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 3/20 0.46
▸ HSP90AB1 P08238 2/20 0.46
▸ CECR2 Q9BXF3 3/20 0.45
▸ BRD9 Q9H8M2 3/20 0.45
▸ BRD4 O60885 2/20 0.45
▸ TAF1 P21675 2/20 0.45
▸ ATM Q13315 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ HTT P42858 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ FKBP1A P62942 2/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ MAPT P10636 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ TAF11 Q15544 1/20 0.39
▸ TAF1L Q8IZX4 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19651852 0.85 BRD4 (0.48) HSP90AA1HSP90AB1CECR2BRD9BRD4
SCHEMBL19657105 0.84 CECR2 (0.47) HSP90AA1HSP90AB1CECR2BRD9BRD4
SCHEMBL19657123 0.81 HSP90AA1 (0.46) HSP90AA1HSP90AB1CECR2BRD9BRD4
SCHEMBL19651863 0.79 HSP90AA1 (0.54) HSP90AA1HSP90AB1CECR2BRD9BRD4
SCHEMBL23809195 0.78 NR3C1 (0.39) ALDH1A1KMT2AL3MBTL1NPC1RAB9A
SCHEMBL24363697 0.77 BRD4 (0.47) HSP90AA1HSP90AB1CECR2BRD9BRD4
SCHEMBL19651856 0.76 HSP90AB1 (0.46) HSP90AA1HSP90AB1CECR2BRD9BRD4
SCHEMBL19657106 0.74 HPGD (0.48) CECR2BRD9BRD4TAF1HTT
SCHEMBL19651815 0.72 HSP90AA1 (0.47) HSP90AA1HSP90AB1ATMRXFP1HTT
SCHEMBL19651819 0.72 MAPT (0.54) HSP90AA1HSP90AB1ATMRXFP1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10183009-B2 Therapeutic compounds and uses thereof GENENTECH, INC. (US) 2019-01-22 — — US disclosed
US-20170340605-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2017-11-30 — — US disclosed
US-20170340605-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2017-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10183009-B2 Therapeutic compounds and uses thereof BRD4, BRDT, BRPF3 HSP90AA1 1632/4885HSP90AB1 1054/4885CECR2 246/4885
US-20170340605-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF BRD4, BRDT, BRPF3 HSP90AA1 1632/4885HSP90AB1 1054/4885CECR2 246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback